ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
120.930 IP-LS
Project title
Radioligand therapy targeting B7-H3: A novel nanobody-polymer conjugate to treat incurable brain tumors

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Geraths Christian
CIS Biopharma AG
www.uid.admin.ch/Detail.aspx?uid_id=CHE309097042

Scientific management
PSI - Paul Scherrer Institut

Scientific management
Universität Zürich

Scientific management
FHNW - Fachhochschule Nordwestschwe
iz

Implementation Partner


CIS Biopharma AG
www.uid.admin.ch/Detail.aspx?uid_id=CHE309097042